BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research
BHF have entered into a six-year partnership with the Crick, which will support collaboration on cardiovascular research, translation and training amongst other activities.
There are 7.6 million people living with heart and circulatory diseases in the UK, and tragically, 450 people die every day as a result.
To further fundamental understanding of heart development, BHF are providing valuable funding to support new Crick and BHF group leader, Rashmi Priya, who joined the Crick in 2021.
Better diagnosis and treatment of heart diseases
Rashmi Priya says: “The heart is the first organ to develop and function as this is crucial for the survival of embryonic life. During early development, the inner surface of the heart forms a complex network of muscle fibres called trabeculae, which are crucial for blood flow and beating of the heart. Trabeculation defects compromise heart function and increase the risk of heart failure.
“The main goal of my lab is to understand how these crucial muscular structures are formed in a developing heart. We take advantage of zebrafish embryos, as their heart forms in a similar way like us, but they are transparent, which makes it possible for us to see the heart develop at minute details.
“Using advanced microscopic, genetics and biophysical approaches, my lab will examine the growth of trabeculae in real time in a developing zebrafish embryo and identify processes and molecules shaping these crucial structures. The outcomes will help us identify better diagnosis and treatment of heart diseases. I am grateful to the BHF for supporting our work.”
Rebecca Wilson, Head of Strategic Partnerships at the Crick adds: “This is our first partnership with the British Heart Foundation, and we’re looking forward to see how we can collaborate in more ways to support the study of cardiovascular health and disease.”
Vital piece of the puzzle
Professor Metin Avkiran, BHF Associate Medical Director, said: “Understanding how the heart develops is a vital piece of the puzzle to understanding heart and circulatory disease. This research could hold the key to unlocking the mystery of why some hearts are more susceptible to heart disease than others. We are incredibly excited about the discoveries that could be yielded by partnering with the Francis Crick Institute, and the potential lives that could be saved.”
Peter Ratcliffe, Clinical Director at the Crick says: “This is a great example of the biomedical research community working together to progress understanding of a group of diseases which affect so many lives, and for which there is still much for science to uncover.”
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more